Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Smith & Nephew Snats ( (SNN) ) has shared an update.
Smith & Nephew plc, a company known for its medical devices and advanced wound management products, announced on April 1, 2025, that its total issued share capital as of March 31, 2025, comprises 877,710,150 ordinary shares, with 1,782,348 held in treasury. This announcement is significant for shareholders as it provides the necessary denominator for determining notification requirements under the FCA’s Disclosure Guidance and Transparency Rules, impacting their interest notifications in the company.
More about Smith & Nephew Snats
YTD Price Performance: 17.28%
Average Trading Volume: 787,187
Technical Sentiment Signal: Sell
Current Market Cap: $12.09B
For detailed information about SNN stock, go to TipRanks’ Stock Analysis page.